PDB Short entry for 3SFI HEADER TRANSCRIPTION REPRESSOR/INHIBITOR 13-JUN-11 3SFI TITLE ETHIONAMIDE BOOSTERS PART 2: COMBINING BIOISOSTERIC REPLACEMENT AND TITLE 2 STRUCTURE-BASED DRUG DESIGN TO SOLVE PHARMACOKINETIC ISSUES IN A TITLE 3 SERIES OF POTENT 1,2,4-OXADIAZOLE ETHR INHIBITORS. COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSCRIPTIONAL REGULATORY REPRESSOR PROTEIN (TETR-FAMILY); COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 STRAIN: H37RV; SOURCE 5 GENE: ETHR, MT3970, RV3855; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TETR-FAMILY, TRANSCRITPTIONAL REGULATORY REPRESSOR, INHIBITOR, DNA, KEYWDS 2 DNA BINDING PROTEIN, TRANSCRIPTION REPRESSOR-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.FLIPO,M.DESROSES,N.LECAT-GUILLET,B.VILLEMAGNE,N.BLONDIAUX,F.LEROUX, AUTHOR 2 C.PIVETEAU,V.MATHYS,M.P.FLAMENT,J.SIEPMANN,V.VILLERET,A.WOHLKONIG, AUTHOR 3 R.WINTJENS,S.H.SOROR,T.CHRISTOPHE,H.K.JEON,C.LOCHT,P.BRODIN,B.D AUTHOR 4 PREZ,A.R.BAULARD,N.WILLAND REVDAT 5 13-SEP-23 3SFI 1 REMARK SEQADV REVDAT 4 24-JAN-18 3SFI 1 AUTHOR REVDAT 3 09-APR-14 3SFI 1 SOURCE REVDAT 2 25-JAN-12 3SFI 1 JRNL REVDAT 1 07-DEC-11 3SFI 0 JRNL AUTH M.FLIPO,M.DESROSES,N.LECAT-GUILLET,B.VILLEMAGNE,N.BLONDIAUX, JRNL AUTH 2 F.LEROUX,C.PIVETEAU,V.MATHYS,M.P.FLAMENT,J.SIEPMANN, JRNL AUTH 3 V.VILLERET,A.WOHLKONIG,R.WINTJENS,S.H.SOROR,T.CHRISTOPHE, JRNL AUTH 4 H.K.JEON,C.LOCHT,P.BRODIN,B.DEPREZ,A.R.BAULARD,N.WILLAND JRNL TITL ETHIONAMIDE BOOSTERS. 2. COMBINING BIOISOSTERIC REPLACEMENT JRNL TITL 2 AND STRUCTURE-BASED DRUG DESIGN TO SOLVE PHARMACOKINETIC JRNL TITL 3 ISSUES IN A SERIES OF POTENT 1,2,4-OXADIAZOLE ETHR JRNL TITL 4 INHIBITORS. JRNL REF J.MED.CHEM. V. 55 68 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22098589 JRNL DOI 10.1021/JM200825U REMARK 2 REMARK 2 RESOLUTION. 2.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.34 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 10878 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.220 REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 547 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.31 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.37 REMARK 3 REFLECTION IN BIN (WORKING SET) : 788 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.88 REMARK 3 BIN R VALUE (WORKING SET) : 0.2580 REMARK 3 BIN FREE R VALUE SET COUNT : 38 REMARK 3 BIN FREE R VALUE : 0.3580 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1500 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 3 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.07000 REMARK 3 B22 (A**2) : 0.07000 REMARK 3 B33 (A**2) : -0.14000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.241 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.181 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.377 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.922 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.881 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1558 ; 0.019 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2125 ; 1.919 ; 1.966 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 192 ; 5.952 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 72 ;41.218 ;23.611 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 239 ;16.634 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;19.720 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 242 ; 0.116 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1197 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 969 ; 0.952 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1549 ; 1.736 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 589 ; 2.897 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 576 ; 4.595 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3SFI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JUN-11. REMARK 100 THE DEPOSITION ID IS D_1000066139. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-DEC-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS, SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10878 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.310 REMARK 200 RESOLUTION RANGE LOW (A) : 33.570 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.31 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1T56 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE CRYSTALLIZATION BUFFER CONTAINED: REMARK 280 1.4 - 1.65M AMMONIUM SULFATE, 15% GLYCEROL AND 0.1M MES PH6.7. , REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 16.78500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 60.38000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 60.38000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 8.39250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 60.38000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 60.38000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 25.17750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 60.38000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 60.38000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 8.39250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 60.38000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 60.38000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 25.17750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 16.78500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2770 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -16.78500 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 THR A 3 REMARK 465 SER A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 SER A 7 REMARK 465 GLN A 8 REMARK 465 ALA A 9 REMARK 465 SER A 10 REMARK 465 LEU A 11 REMARK 465 PRO A 12 REMARK 465 ARG A 13 REMARK 465 GLY A 14 REMARK 465 ARG A 15 REMARK 465 ARG A 16 REMARK 465 THR A 17 REMARK 465 ALA A 18 REMARK 465 ARG A 19 REMARK 465 PRO A 20 REMARK 465 SER A 21 REMARK 465 ASN A 215 REMARK 465 ARG A 216 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 214 C O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 94 103.62 -56.94 REMARK 500 THR A 97 -178.89 -175.49 REMARK 500 THR A 165 -111.54 -97.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3SF A 217 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3O8G RELATED DB: PDB REMARK 900 ETHR FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH COMPOUND REMARK 900 BDM14801 REMARK 900 RELATED ID: 3O8H RELATED DB: PDB REMARK 900 ETHR FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH COMPOUND REMARK 900 BDM14950 REMARK 900 RELATED ID: 3G1L RELATED DB: PDB REMARK 900 ETHR FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH COMPOUND REMARK 900 BDM14744 REMARK 900 RELATED ID: 3G1M RELATED DB: PDB REMARK 900 ETHR FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH COMPOUND REMARK 900 BDM31381 REMARK 900 RELATED ID: 1U9N RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE TRANSCRIPTIONAL REGULATOR ETHR IN A LIGAND REMARK 900 BOUND CONFORMATION OPENS THERAPEUTIC PERSPECTIVES AGAINST REMARK 900 TUBERCULOSIS AND LEPROSY DBREF 3SFI A 1 216 UNP P96222 ETHR_MYCTU 1 216 SEQADV 3SFI MET A -19 UNP P96222 EXPRESSION TAG SEQADV 3SFI GLY A -18 UNP P96222 EXPRESSION TAG SEQADV 3SFI SER A -17 UNP P96222 EXPRESSION TAG SEQADV 3SFI SER A -16 UNP P96222 EXPRESSION TAG SEQADV 3SFI HIS A -15 UNP P96222 EXPRESSION TAG SEQADV 3SFI HIS A -14 UNP P96222 EXPRESSION TAG SEQADV 3SFI HIS A -13 UNP P96222 EXPRESSION TAG SEQADV 3SFI HIS A -12 UNP P96222 EXPRESSION TAG SEQADV 3SFI HIS A -11 UNP P96222 EXPRESSION TAG SEQADV 3SFI HIS A -10 UNP P96222 EXPRESSION TAG SEQADV 3SFI SER A -9 UNP P96222 EXPRESSION TAG SEQADV 3SFI SER A -8 UNP P96222 EXPRESSION TAG SEQADV 3SFI GLY A -7 UNP P96222 EXPRESSION TAG SEQADV 3SFI LEU A -6 UNP P96222 EXPRESSION TAG SEQADV 3SFI VAL A -5 UNP P96222 EXPRESSION TAG SEQADV 3SFI PRO A -4 UNP P96222 EXPRESSION TAG SEQADV 3SFI ARG A -3 UNP P96222 EXPRESSION TAG SEQADV 3SFI GLY A -2 UNP P96222 EXPRESSION TAG SEQADV 3SFI SER A -1 UNP P96222 EXPRESSION TAG SEQADV 3SFI HIS A 0 UNP P96222 EXPRESSION TAG SEQRES 1 A 236 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 236 LEU VAL PRO ARG GLY SER HIS MET THR THR SER ALA ALA SEQRES 3 A 236 SER GLN ALA SER LEU PRO ARG GLY ARG ARG THR ALA ARG SEQRES 4 A 236 PRO SER GLY ASP ASP ARG GLU LEU ALA ILE LEU ALA THR SEQRES 5 A 236 ALA GLU ASN LEU LEU GLU ASP ARG PRO LEU ALA ASP ILE SEQRES 6 A 236 SER VAL ASP ASP LEU ALA LYS GLY ALA GLY ILE SER ARG SEQRES 7 A 236 PRO THR PHE TYR PHE TYR PHE PRO SER LYS GLU ALA VAL SEQRES 8 A 236 LEU LEU THR LEU LEU ASP ARG VAL VAL ASN GLN ALA ASP SEQRES 9 A 236 MET ALA LEU GLN THR LEU ALA GLU ASN PRO ALA ASP THR SEQRES 10 A 236 ASP ARG GLU ASN MET TRP ARG THR GLY ILE ASN VAL PHE SEQRES 11 A 236 PHE GLU THR PHE GLY SER HIS LYS ALA VAL THR ARG ALA SEQRES 12 A 236 GLY GLN ALA ALA ARG ALA THR SER VAL GLU VAL ALA GLU SEQRES 13 A 236 LEU TRP SER THR PHE MET GLN LYS TRP ILE ALA TYR THR SEQRES 14 A 236 ALA ALA VAL ILE ASP ALA GLU ARG ASP ARG GLY ALA ALA SEQRES 15 A 236 PRO ARG THR LEU PRO ALA HIS GLU LEU ALA THR ALA LEU SEQRES 16 A 236 ASN LEU MET ASN GLU ARG THR LEU PHE ALA SER PHE ALA SEQRES 17 A 236 GLY GLU GLN PRO SER VAL PRO GLU ALA ARG VAL LEU ASP SEQRES 18 A 236 THR LEU VAL HIS ILE TRP VAL THR SER ILE TYR GLY GLU SEQRES 19 A 236 ASN ARG HET 3SF A 217 25 HETNAM 3SF 5,5,5-TRIFLUORO-1-{4-[3-(1,3-THIAZOL-2-YL)-1,2,4- HETNAM 2 3SF OXADIAZOL-5-YL]PIPERIDIN-1-YL}PENTAN-1-ONE FORMUL 2 3SF C15 H17 F3 N4 O2 S FORMUL 3 HOH *3(H2 O) HELIX 1 1 GLY A 22 ARG A 40 1 19 HELIX 2 2 SER A 46 GLY A 55 1 10 HELIX 3 3 SER A 57 PHE A 65 1 9 HELIX 4 4 SER A 67 ASN A 93 1 27 HELIX 5 5 ASP A 98 SER A 116 1 19 HELIX 6 6 HIS A 117 ALA A 127 1 11 HELIX 7 7 SER A 131 ARG A 159 1 29 HELIX 8 8 PRO A 167 ALA A 188 1 22 HELIX 9 9 PRO A 195 GLY A 213 1 19 CISPEP 1 GLN A 191 PRO A 192 0 -1.75 SITE 1 AC1 14 MET A 102 GLY A 106 ILE A 107 PHE A 110 SITE 2 AC1 14 PHE A 114 TRP A 138 TRP A 145 TYR A 148 SITE 3 AC1 14 THR A 149 ASN A 176 ASN A 179 GLU A 180 SITE 4 AC1 14 PHE A 184 TRP A 207 CRYST1 120.760 120.760 33.570 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008281 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008281 0.000000 0.00000 SCALE3 0.000000 0.000000 0.029789 0.00000